Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2011
Identification of novel, potent and selective inhibitors of Polo-like kinase 1
Shaoqing Chen, David Bartkovitz, Jianping Cai, et al.
The ISME Journal
|
August 5, 2022
Dietary selection of metabolically distinct microorganisms drives hydrogen metabolism in ruminants
Qiu Shuang Li, Rong Wang, Zhi Yuan Ma, et al.
Blood. Red Cells & Iron
|
March 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease
Anna Conrey, Nancy Asomaning, Ingrid Frey, et al.
Pain
|
April 19, 2021
Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments
Jiacheng Ma, Sunil Goodwani, Paul J Acton, et al.
Journal of Medicinal Chemistry
|
July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Kang Le, Michael J Soth, Jason B Cross, et al.
Journal of Medicinal Chemistry
|
October 3, 2013
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain
Andrew F Donnell, Christophe Michoud, Kenneth C Rupert, et al.
Journal of Medicinal Chemistry
|
October 8, 2013
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain
Robert F Kester, Andrew F Donnell, Yan Lou, et al.
Nature
|
August 6, 2025
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers
Jinho Jeong, Simone Hausmann, Hanyang Dong, et al.
Journal of Medicinal Chemistry
|
October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Michael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Nature Communications
|
November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Melinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2011
Identification of novel, potent and selective inhibitors of Polo-like kinase 1
Shaoqing Chen, David Bartkovitz, Jianping Cai, et al.
The ISME Journal
|
August 5, 2022
Dietary selection of metabolically distinct microorganisms drives hydrogen metabolism in ruminants
Qiu Shuang Li, Rong Wang, Zhi Yuan Ma, et al.
Blood. Red Cells & Iron
|
March 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease
Anna Conrey, Nancy Asomaning, Ingrid Frey, et al.
Pain
|
April 19, 2021
Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments
Jiacheng Ma, Sunil Goodwani, Paul J Acton, et al.
Journal of Medicinal Chemistry
|
July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Kang Le, Michael J Soth, Jason B Cross, et al.
Journal of Medicinal Chemistry
|
October 3, 2013
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain
Andrew F Donnell, Christophe Michoud, Kenneth C Rupert, et al.
Journal of Medicinal Chemistry
|
October 8, 2013
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain
Robert F Kester, Andrew F Donnell, Yan Lou, et al.
Nature
|
August 6, 2025
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers
Jinho Jeong, Simone Hausmann, Hanyang Dong, et al.
Journal of Medicinal Chemistry
|
October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Michael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Nature Communications
|
November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Melinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Page
of 10